Global Medical REIT Stock Forecast, Price & News

-0.02 (-0.14 %)
(As of 04/14/2021 12:00 AM ET)
Today's Range
Now: $13.83
50-Day Range
MA: $13.64
52-Week Range
Now: $13.83
Volume343,349 shs
Average Volume508,490 shs
Market Capitalization$721.50 million
P/E RatioN/A
Dividend Yield5.99%
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Global Medical REIT logo

Industry, Sector and Symbol

Industry Real estate investment trusts
Year FoundedN/A



Sales & Book Value

Annual Sales$70.73 million
Cash Flow$0.87 per share
Book Value$10.45 per share


Net Income$9.23 million


Market Cap$721.50 million
Next Earnings Date5/5/2021 (Estimated)


Outlook Brightens for Adobe Shares
March 27, 2021 |  finance.yahoo.com
Global Medical REIT, Inc. to Host Earnings Call
March 4, 2021 |  finance.yahoo.com
Global Medical REIT: Q4 Earnings Snapshot
March 3, 2021 |  finance.yahoo.com
Understanding Global Medical REIT's Ex-Dividend Date
December 23, 2020 |  finance.yahoo.com
Global Medical REIT FFO misses by $0.24, beats on revenue
November 4, 2020 |  seekingalpha.com
See More Headlines


Overall MarketRank

1.84 out of 5 stars

Finance Sector

299th out of 1,953 stocks

Real Estate Investment Trusts Industry

66th out of 274 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
-0.02 (-0.14 %)
(As of 04/14/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

Is Global Medical REIT a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Global Medical REIT stock.
View analyst ratings for Global Medical REIT
or view top-rated stocks.

What stocks does MarketBeat like better than Global Medical REIT?

Wall Street analysts have given Global Medical REIT a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Global Medical REIT wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a increase in short interest during the month of February. As of February 26th, there was short interest totaling 938,200 shares, an increase of 24.7% from the February 11th total of 752,300 shares. Based on an average trading volume of 384,600 shares, the days-to-cover ratio is presently 2.4 days.
View Global Medical REIT's Short Interest

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Global Medical REIT

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) issued its quarterly earnings results on Thursday, March, 4th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by $0.02. Global Medical REIT had a negative trailing twelve-month return on equity of 1.46% and a negative net margin of 6.11%.
View Global Medical REIT's earnings history

How has Global Medical REIT's stock been impacted by Coronavirus?

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, GMRE shares have increased by 11.4% and is now trading at $13.83.
View which stocks have been most impacted by COVID-19

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Tuesday, March 2nd. Stockholders of record on Wednesday, March 24th will be given a dividend of $0.205 per share on Thursday, April 8th. This represents a $0.82 annualized dividend and a yield of 5.93%. The ex-dividend date of this dividend is Tuesday, March 23rd. This is a boost from Global Medical REIT's previous quarterly dividend of $0.20.
View Global Medical REIT's dividend history

Is Global Medical REIT a good dividend stock?

Global Medical REIT pays an annual dividend of $0.82 per share and currently has a dividend yield of 5.99%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Global Medical REIT does not yet have a strock track record of dividend growth. The dividend payout ratio of Global Medical REIT is 109.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 81.19% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.
View Global Medical REIT's dividend history.

What price target have analysts set for GMRE?

2 analysts have issued 12-month target prices for Global Medical REIT's shares. Their forecasts range from $13.00 to $15.00. On average, they expect Global Medical REIT's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 1.2% from the stock's current price.
View analysts' price targets for Global Medical REIT
or view top-rated stocks among Wall Street analysts.

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the following people:
  • Mr. Jeffrey M. Busch, Chairman, Pres & CEO (Age 61, Pay $141.37k)
  • Mr. Robert J. Kiernan CPA, CFO & Treasurer (Age 55, Pay $54.26k)
  • Mr. Alfonzo Leon, Chief Investment Officer (Age 45, Pay $64.83k)
  • Mr. Jamie A. Barber, Gen. Counsel & Corp. Sec. (Age 44, Pay $44.47k)
  • Ms. Danica Holley, Chief Operating Officer (Age 48)
  • Ms. Mary Jensen, Investor Relations Professional

Who are some of Global Medical REIT's key competitors?

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Square (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Sound Income Strategies LLC (0.21%), Pensionfund DSM Netherlands (0.06%), Mesirow Financial Investment Management Inc. (0.05%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends for Global Medical REIT

Which institutional investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Mesirow Financial Investment Management Inc..
View insider buying and selling activity for Global Medical REIT
or view top insider-selling stocks.

Which institutional investors are buying Global Medical REIT stock?

GMRE stock was purchased by a variety of institutional investors in the last quarter, including Sound Income Strategies LLC, Pensionfund DSM Netherlands, and State of Alaska Department of Revenue. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, and Ronald Marston.
View insider buying and selling activity for Global Medical REIT
or or view top insider-buying stocks.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $13.83.

How much money does Global Medical REIT make?

Global Medical REIT has a market capitalization of $721.50 million and generates $70.73 million in revenue each year. The company earns $9.23 million in net income (profit) each year or $0.75 on an earnings per share basis.

How many employees does Global Medical REIT have?

Global Medical REIT employs 22 workers across the globe.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is www.globalmedicalreit.com.

Where are Global Medical REIT's headquarters?

Global Medical REIT is headquartered at 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851 or via email at [email protected]

This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.